Probiotics and Preterm Infants: Do We Need More Research or Action?

Program Date: 11 October 2022
Publication Date: 13 April 2023
Continuing Education Units: Nurse Contact: 1.0; Dietitian CPEU: 1.0

Course Description:

In this course, Stefan Johansson, MD, PhD and Adam Baker, PhD will compare and contrast the safety and manufacturing of probiotic products; describe the principles of evidence-based practice and preclinical data; review current probiotic research; and discuss outcomes from a real-world implementation of probiotics in the NICU. Originally presented as a live webinar on October 17, 2022.

Course Objectives:

• Compare and contrast the safety and manufacturing of probiotic products. 
• Describe the principles of evidence-based practice and preclinical data and how this relates to the infant microbiome and probiotics. 
• Review current probiotic research and ESPGHAN and AAP position statements about probiotics in the preterm infant. 
• Discuss outcomes from a real-world implementation of probiotics in the NICU.
  • CDR Level: 2
  • Performance Indicators: 8.1.1, 8.1.4, 8.1.5
  • Run Time: 43

Course Instructor Bio(s)

Headshot placeholder

Stefan Johansson, MD, PhD

Consultant Neonatologist, Sachs’ Children and Youth Hospital 
Associate Professor, Clinical Epidemiology Division 
Karolinska Institutet Stockholm, Sweden
Stefan Johansson is a Consultant Neonatologist and Associate Professor and has a PhD in epidemiology and biostatistics at Karolinska Institutet. He founded and, and has vast knowledge in research design through several large-scale projects.
Headshot placeholder

Adam Baker, PhD

Director of Science, Human Health 
Christian Hansen Human Health 
Hørsholm, Denmark
Dr Baker leads the Human Health and Microbiome Research and Development team who is responsible for the research of current and next-generation probiotics, and the development of technical in vitro and in vivo discovery platforms for mode of action research. Prior to Chr. Hansen, he worked as the VP of Diagnostic Product Development at Exiqon A/S in Denmark for 5 years and the Head of New Technologies in deCODE Genetics in Iceland. Both roles focused on the development of new insights and therapeutics to support the clinical treatment of complex diseases. In addition, Dr Baker has held positions in Vancouver, Canada and Boehringer Ingelheim in Vienna Austria.
Picture of Karyn Wulf, MD, MPH,

Karyn Wulf, MD, MPH

Medical Director, Pediatrics 
Abbott Nutrition Products Division 
Columbus, OH, USA
Dr Karyn Wulf joined Abbott Nutrition as Pediatric Medical Director in 2018 after working clinically for 16 years as a general pediatrician in emergency medicine. She maintains her clinical activities on a part-time basis. She attended the University of Pittsburgh School of Medicine with a dual degree in Medicine and Public Health in 1999. She completed her internship and residency in general pediatrics at The Johns Hopkins Hospital in 2002. During her clinical practice, Dr Wulf was actively involved in medical education and taught medical students, residents, and faculty and held faculty appointments at Baylor College of Medicine (2007-2009) and The Ohio State University School of Medicine (2009-2018). Her research interests include pediatric malnutrition screening and mentoring best practices for women in medicine and science.

You Must LOG IN to Enroll


attended a live program?




continuing medical education courses